Page last updated: 2024-09-03

gefitinib and Airway Hyper-Responsiveness

gefitinib has been researched along with Airway Hyper-Responsiveness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hur, GY; In, KH; Jung, JY; Jung, KH; Kang, EH; Kang, KH; Kim, JH; Kim, SJ; Lee, EJ; Lee, KJ; Lee, SH; Lee, SY; Shim, JJ; Shin, C; Yoo, SH	1

Other Studies

1 other study(ies) available for gefitinib and Airway Hyper-Responsiveness

Article	Year
Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation. Experimental & molecular medicine, 2007, Jun-30, Volume: 39, Issue:3 Topics: Animals; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Cytokines; Enzyme Activation; Eosinophils; ErbB Receptors; Gefitinib; Goblet Cells; Inflammation; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Respiratory Hypersensitivity; Respiratory Mucosa	2007

Article

Year

Potential use of an anticancer drug gefinitib, an EGFR inhibitor, on allergic airway inflammation.

Experimental & molecular medicine, 2007, Jun-30, Volume: 39, Issue:3

Topics: Animals; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Cytokines; Enzyme Activation; Eosinophils; ErbB Receptors; Gefitinib; Goblet Cells; Inflammation; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Respiratory Hypersensitivity; Respiratory Mucosa

2007